More contagious Omicron sub-variant makes up over a tenth of COVID variants in U.S. - CDC
Eoneren/E+ via Getty Images
The BA.2 sub-variant of Omicron is estimated to make up nearly 12% of all COVID-19 variants circulating in the U.S., the latest genomic surveillance data from the Centers for Disease Control and Prevention (CDC) indicate.
Last month the World Health Organization (WHO) cited early data to warn that BA.2 is more transmissible than the original BA.1 sub-variant of Omicron.
Based on data from South Africa, Dr. John Nkengasong, the head of Africa's top public health body, said last month that BA.2 does not appear to cause more severe disease than the original BA.1 sub-variant.
BA.1.1, a second-generation sub-lineage of the Omicron variant, currently accounts for ~74% of sequenced cases, the CDC data for the week ending Mar. 05, indicate.
Recent studies indicated that BA.2 is resistant to nearly all monoclonal antibodies developed for COVID-19, including sotrovimab from GlaxoSmithKline (NYSE:GSK) and Vir Biotechnology (NASDAQ:VIR) which was earlier thought to be effective against the original Omicron variant.
In late February, the U.S. Food and Drug Administration (FDA) warned against the use of sotrovimab in places with COVID-19 variants that are not suspectable to the drug.
Recommended For You
Comments (13)
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Anyone believing the PR crap that any of the trial vaccines work in any way is delusional. The S Protein is a complex mutation of previous variants & between each notable variant there's several sequences. Even if the mRNA vaccines were safe and easy to alter they haven't yet made one that's successful against any SARS virus including Covid-19 and they aren't going to, any more than they'll cure the common cold.. which right now is nastier than the latest variant of Covid.



( in their WMMR from July)

